Abstract：Objective To investigate the immunization level of hepatitis B among population in Hubei Province, and to provide a basis for developing strategies for hepatitis B prevention and control. Methods Hepatitis B surface antigen (HBsAg) and hepatitis B surface antibody (HBsAb) levels were monitored in 8 cities (including 15 counties and 45 communities) selected by using a multi-stage stratified random sampling method in Hubei Province from 2015 to 2018. Results HBsAg carrier rate and the positive rate of HBsAb in population in Hubei Province were 2.67% and 66.08%, respectively. There were statistically significant differences in HBsAg carrier rate and the positive rate of HBsAb among areas (HBsAg: χ2=60.430, P=0.000; HBsAb: χ2=215.599,P=0.000), ages(HBsAg: χ2=109.341, P=0.000; HBsAb: χ2=265.578, P=0.000), occupations (HBsAg: χ2=70.919, P=0.000; HBsAb: χ2=480.782, P=0.000) and immunization history (HBsAg: χ2=36.725, P=0.000; HBsAb: χ2=27.653, P=0.000). HBsAg carrier rate was found to be higher in people aged above 20 years(≥5.64%), workers(7.59%), farmers(5.99%)and service workers(5.45%). The positive rate of HBsAb was found to be lower in young people aged 7-14 years(57.06%), farmers (58.98%), students (60.71%) and workers(60.76%). Conclusions Hepatitis B prevention and control in Hubei Province has made certain achievements, but it is still necessary toimplement intervention measures likeincreasing publicity and education, improving the vaccination rate of hepatitis B vaccine in the key population (including people aged above 20 years, workers, farmers, service workers and students) and carrying out supplementary immunization, which are conducive to reducing the risk of hepatitis B infection.
骆金俊, 王四全, 王雷, 赵明江. 2015—2018年湖北省全人群乙型病毒性肝炎免疫水平监测分析[J]. 实用预防医学, 2021, 28(1): 66-69.
LUO Jin-jun, WANG Si-quan, WANG-Lei, ZHAO Ming-jiang. Surveillance on hepatitis B immunization level among population in Hubei Province, 2015-2018. , 2021, 28(1): 66-69.
[1] 卫生部疾病预防控制局,中国疾病预防控制中心.全国人群乙型病毒性肝炎血清流行病学调查报告[M].北京,人民卫生出版社,2011:2-28,55. [2] 杨北方.湖北省人群乙型病毒性肝炎血清流行病学特征及乙肝疫苗免疫效果分析[D].武汉:华中科技大学,2013. [3] Zhang W, Ji Z, Wang L, et al.A meta-analysis of HBsAg-positive rate among general Chinese populations aged 1-59 years [J].Infect Dis (Lond), 2015, 47(12):878-888. [4] 蔡军,朱宝,郑珂,等.2014年成都市健康人群乙脑、乙肝抗体水平监测[J].预防医学情报杂志,2016,32(9):898-901. [5] Banks T, Kang J, Watts I, et al.High hepatitis B seroprevalence and risk factors for infection in pregnant women on the Thailand-Myanmar Border [J].J Infect Dev Ctries, 2016, 10(4):384-388. [6] 金之彪.2013—2015年云南永胜县健康人群麻疹及乙肝抗体水平监测分析[J].热带病与寄生虫学,2017,15(1):25-27. [7] 张清慧,李萌,孔园园,等.2006—2015年上海市松江区乙型病毒性肝炎流行状况及防控效果评价[J].实用预防医学,2017,24(6):716-719. [8] 范晨璐,姜立坤,杨淑云,等.哈尔滨市乙型病毒性肝炎血清流行病学分析[J].实用预防医学,2017,24(12):1495-1498. [9] 徐菲,程慧健,熊英,等.2013年江西省部分地区 0～4岁儿童麻疹、风疹、乙脑、乙肝、脊灰抗体水平调查[J].实验与检验医学,2016,34(5):673-675. [10] 黄玉莲,李霞,蔺洁,等.克拉玛依市3~14岁儿童麻疹、腮腺炎、白喉、乙肝、甲肝抗体水平分析[J].现代预防医学,2017,44(13):2368-2371. [11] 朱宝,郑珂,蔡军,等.2016年成都市健康人群乙型肝炎表面抗体水平监测分析[J].预防医学情报杂志,2017,33(7):639-641. [12] 黄烈雨,洪宝林,吕敏,等. 北京市1992－2013年乙肝疫苗免疫规划对急性乙肝成本效果分析[J].实用预防医学,2019,26(12):1437-1440.
2021, Vol. 28 
